logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabVitiligo and worsening of hypothyroidism following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1886卷 / 1期
关键词:
D O I:
10.1007/s40278-021-07503-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:238 / 238
相关论文
共 50 条
  • [31] CatequentinibPneumothorax following off-label use: case report
    Reactions Weekly, 2022, 1925 (1) : 158 - 158
  • [32] TolvaptanHypernatraemia following off-label use: case report
    Reactions Weekly, 2019, 1753 (1) : 326 - 326
  • [33] FelbamateNeutropenia following off-label use: case report
    Reactions Weekly, 2020, 1803 (1) : 111 - 111
  • [34] MethylprednisoloneFungaemia following an off-label use: case report
    Reactions Weekly, 2022, 1899 (1) : 243 - 243
  • [35] SirolimusPneumonia following off-label use: case report
    Reactions Weekly, 2020, 1800 (1) : 269 - 269
  • [36] ClonazepamMisidentification following off-label use: case report
    Reactions Weekly, 2022, 1926 (1) : 171 - 171
  • [37] RituximabAgranulocytosis following off-label use: case report
    Reactions Weekly, 2018, 1712 (1) : 482 - 482
  • [38] InsulinHypoglycaemia following off-label use: case report
    Reactions Weekly, 2021, 1843 (1) : 204 - 204
  • [39] GalcanezumabConstipation following off-label use: case report
    Reactions Weekly, 2025, 2046 (1) : 169 - 169
  • [40] BevacizumabCataract following off-label use: case report
    Reactions Weekly, 2019, 1747 (1) : 63 - 63
← 12345 →